Book FT4 Test: Purpose, Normal Range and Price

The FT4 test is a blood test that measures the level of free thyroxine, the unbound and biologically active form of the thyroid hormone T4 produced by the thyroid gland. The thyroid gland produces two main hormones, T4 and T3, under the control of TSH secreted by the pituitary gland. The vast majority of T4 in the bloodstream is bound to carrier proteins such as thyroxine-binding globulin and is biologically inactive. Only a small fraction, approximately 0.03%, circulates as free T4 and is available to enter cells and exert its metabolic effects. Measuring free T4 rather than total T4 provides a more accurate and clinically reliable assessment of thyroid hormone status as it is unaffected by changes in binding protein levels caused by pregnancy, liver disease, and medications. Thyroid disorders are among the most prevalent endocrine conditions in India, with an estimated 42 million Indians affected by thyroid disease, predominantly hypothyroidism and autoimmune thyroiditis. FT4 is the essential companion test to TSH in the diagnosis and monitoring of all thyroid disorders. While TSH is the most sensitive initial screening marker, FT4 quantifies the actual hormone level and is indispensable for grading the severity of thyroid dysfunction, diagnosing central hypothyroidism where TSH is falsely normal despite low FT4, and monitoring thyroid hormone replacement therapy. The test involves a simple blood draw completed in under five minutes.

Doctors prescribe an FT4 test in the following situations: Confirming hypothyroidism severity in patients with an elevated TSH where FT4 measurement determines whether the hypothyroidism is subclinical with normal FT4 or overt with low FT4, a distinction that directly guides the decision to initiate levothyroxine therapy. Diagnosing hyperthyroidism in patients with symptoms of thyroid overactivity including palpitations, weight loss, tremor, heat intolerance, and anxiety where a low TSH alongside elevated FT4 confirms overt hyperthyroidism requiring antithyroid treatment. Monitoring levothyroxine replacement therapy in patients with hypothyroidism where FT4 alongside TSH confirms that the prescribed dose is achieving the therapeutic target and guides dose adjustments to maintain optimal thyroid hormone levels. Diagnosing central hypothyroidism caused by pituitary or hypothalamic dysfunction where TSH is inappropriately normal or low despite reduced thyroid hormone production, making FT4 the primary diagnostic parameter rather than TSH. Evaluating thyroid status in pregnancy where physiological changes including elevated thyroxine-binding globulin and increased metabolic demands alter TSH reference ranges, making FT4 alongside trimester-specific TSH targets essential for accurate thyroid assessment and management of gestational hypothyroidism. Investigating non-thyroidal illness syndrome in hospitalised patients where acute illness suppresses TSH and lowers FT4 as part of a physiological adaptive response, which must be distinguished from true thyroid disease before initiating unnecessary treatment. Monitoring antithyroid therapy with carbimazole or propylthiouracil in patients with hyperthyroidism where serial FT4 measurements confirm disease control and guide dose reduction as thyroid function normalises.

The FT4 test measures the concentration of free thyroxine in the blood, reported in picograms per millilitre (pg/mL) or picomoles per litre (pmol/L). Normal FT4 Range in India The standard reference ranges used across most Indian diagnostic laboratories are as follows. For adults, a normal FT4 level is between 0.8 and 1.8 ng/dL or 10 and 23 pmol/L. Reference ranges may vary slightly between laboratories depending on the immunoassay platform used. Interpreting FT4 Results A low FT4 below 0.8 ng/dL alongside an elevated TSH confirms overt primary hypothyroidism requiring levothyroxine replacement therapy. The degree of FT4 suppression broadly correlates with the clinical severity of hypothyroidism and guides the initial levothyroxine dose. A normal FT4 alongside an elevated TSH confirms subclinical hypothyroidism where the pituitary is compensating for early thyroid underperformance. Treatment decisions in subclinical hypothyroidism are based on TSH level, symptoms, pregnancy status, and cardiovascular risk rather than FT4 alone. An elevated FT4 above 1.8 ng/dL alongside a suppressed TSH confirms overt hyperthyroidism requiring antithyroid treatment. A markedly elevated FT4 above 3.0 ng/dL with a fully suppressed TSH indicates severe hyperthyroidism or thyroid storm requiring urgent specialist management. A low FT4 with a normal or low TSH raises concern for central hypothyroidism from pituitary or hypothalamic disease and requires pituitary MRI and complete anterior pituitary hormone evaluation.

No fasting is strictly required for the FT4 test alone. However if FT4 is part of a broader hormonal or metabolic panel that includes fasting parameters, fast as advised by your doctor. Our team confirms preparation requirements at the time of booking. Ideally collect the sample in the morning as TSH and thyroid hormones show mild diurnal variation with slightly higher levels in the morning. This is particularly important when FT4 is being used to monitor levothyroxine therapy. Inform the phlebotomist about all thyroid medications you are currently taking. If you are on levothyroxine, do not take your morning dose before the blood test as this produces a transient post-absorption spike in FT4 that does not reflect your true steady-state thyroid hormone level. Take your levothyroxine after the blood draw. Inform your doctor about all other medications including oestrogens, androgens, corticosteroids, amiodarone, lithium, and biotin supplements as these can affect both thyroid function and thyroid hormone assay results. Stay normally hydrated before sample collection.

If you are booking through the SecondMedic platform the FT4 test price starts at approximately Rs. 290. The exact price will be confirmed at the time of booking through SecondMedic. If your doctor has prescribed multiple tests alongside FT4, SecondMedic health packages include FT4 as part of a broader thyroid function or endocrine panel at a significantly lower combined price.

SecondMedic provides home sample collection for FT4 test across all major areas in India. You do not need to visit a lab or collection centre. A certified and trained phlebotomist comes to your home or workplace at your chosen time, collects the sample using sterile single-use equipment, and ensures it is transported to the NABL-accredited lab within the required time window for accurate processing. Please note that SecondMedic provides free home sample collection on all tests priced above Rs. 300. Our team will check your pincode and confirm if your address falls under our free sample collection eligibility criteria, which depends upon the lab location and phlebotomist availability. Home collection is available between 7 AM and 10 PM, seven days a week, including Sundays and public holidays. Enter your pincode on the booking page or call our helpline to confirm availability at your address.

People Also Ask

The vast majority of T4 in the blood is bound to carrier proteins and biologically inactive. Only free T4, approximately 0.03% of total T4, enters cells and exerts metabolic effects. Total T4 is significantly affected by changes in binding protein levels caused by pregnancy, liver disease, and oestrogen therapy, making it an unreliable indicator of true thyroid status. Free T4 is independent of these binding protein changes and provides a more accurate assessment.

Levothyroxine is absorbed rapidly after oral ingestion and produces a transient peak in serum FT4 within 2 to 4 hours of the dose that does not reflect the patient's true steady-state thyroid hormone level. Testing during this absorption peak can falsely suggest adequate or excess replacement when the patient may actually be under-replaced at other times of day. Taking the dose after the blood draw ensures the result reflects the true baseline FT4 level.

Central hypothyroidism is caused by insufficient TSH secretion from the pituitary gland or insufficient TRH stimulation from the hypothalamus, resulting in reduced thyroid stimulation and low T4 production. Because TSH is the deficient signal itself in this condition, it is inappropriately normal or low despite inadequate thyroid hormone levels. FT4 therefore becomes the primary diagnostic marker, as it directly measures the hormone the patient is lacking.

During pregnancy, rising oestrogen levels stimulate increased production of thyroxine-binding globulin, which binds more T4 and lowers free T4 in the first trimester. The placenta also produces hCG, which mildly stimulates the thyroid. These physiological changes alter both TSH and FT4 reference ranges across each trimester. Trimester-specific reference ranges must be used for accurate interpretation, as applying standard adult ranges leads to both overdiagnosis and underdiagnosis of thyroid disorders in pregnancy.

Thyroid storm is a life-threatening emergency characterised by extreme hyperthyroid excess causing high fever, rapid heart rate, heart failure, and altered consciousness. An FT4 markedly above 3.0 ng/dL alongside a fully suppressed TSH in a patient with clinical deterioration raises urgent concern for this condition. Thyroid storm requires immediate hospitalisation, high-dose antithyroid drugs, beta-blockers, corticosteroids, and supportive intensive care.

Amiodarone, a cardiac antiarrhythmic drug widely used in India, contains approximately 37% iodine by weight and profoundly affects thyroid function in multiple ways. It inhibits the conversion of T4 to active T3, causing FT4 to rise in euthyroid patients. It can also cause both amiodarone-induced hypothyroidism and amiodarone-induced thyrotoxicosis. Regular FT4 and TSH monitoring every 6 months is mandatory in all patients receiving amiodarone therapy.

Non-thyroidal illness syndrome, previously called sick euthyroid syndrome, is a physiological adaptive response to severe acute illness, surgery, or starvation where TSH is suppressed and FT4 falls without true thyroid disease. The low FT4 in this context reflects a metabolic adaptation rather than hypothyroidism and typically resolves when the underlying illness improves. Initiating levothyroxine in this setting is generally not beneficial and may worsen outcomes.

Many immunoassay platforms used to measure FT4 use biotin-streptavidin chemistry in their detection systems. High-dose biotin supplements, which are widely consumed in India for hair and nail growth, can interfere with these assays and produce falsely elevated FT4 results alongside falsely suppressed TSH, mimicking hyperthyroidism in a euthyroid patient. Biotin should be stopped for at least 48 hours before thyroid function testing.

After initiating or adjusting levothyroxine, FT4 alongside TSH should be rechecked 6 to 8 weeks later to allow the new steady state to be reached. Once the dose is stable and TSH is in the target range, annual monitoring is appropriate for most patients. More frequent monitoring is required during pregnancy, after significant illness or weight change, and in elderly patients where levothyroxine requirements fluctuate.